Related Experiment Video
Updated: Jul 1, 2025

10:04
Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates
Published on: September 5, 2017
18.8K
Granular Cell Tumor of the Breast: Radiologic-Pathologic Correlation
Suzanne M Ghannam1, Gloria J Carter1, Tatiana M Villatoro1
1Magee-Womens Hospital of University of Pittsburgh Medical Center, Department of Radiology, Pittsburgh, PA, USA.
Journal of Breast Imaging
|March 1, 2024
Summary
Granular cell tumors (GCTs) are rare breast neoplasms that can mimic malignancy on imaging. Diagnosis requires core biopsy, and while locally aggressive, benign GCTs are curable with surgical excision.
Area of Science:
- Oncology
- Pathology
- Radiology
Background:
- Granular cell tumors (GCTs) are uncommon neoplasms originating from perineural Schwann cells.
- GCTs can occur anywhere but are rare in the breast, often presenting as irregular, noncalcified masses.
- Imaging findings on mammography and ultrasound can mimic malignancy, necessitating further investigation.
Purpose of the Study:
- To describe the characteristics of breast granular cell tumors.
- To highlight the diagnostic challenges and immunohistochemical features of GCTs.
- To emphasize the clinical behavior and management of GCTs.
Main Methods:
- Review of imaging findings (mammography, ultrasound).
- Histopathological analysis of core biopsies.
- Immunohistochemical staining for S-100, CD68, cytokeratin, estrogen, and progesterone receptors.
Main Results:
- GCTs present as irregular masses with high mammographic density and posterior shadowing on ultrasound.
- Histopathology reveals polygonal to spindle-shaped cells with eosinophilic granules.
- Immunohistochemistry is positive for S-100 and CD68, and negative for cytokeratin, estrogen, and progesterone.
Conclusions:
- Breast granular cell tumors, though rare, can exhibit local aggressiveness.
- Core biopsy and immunohistochemistry are crucial for accurate diagnosis.
- Wide local excision is curative for the vast majority of benign GCTs.

